LONDON MARKETS: Brexit Stockpiling Shows Up In Manufacturing Data And Bakery Results

Date : 10/01/2019 @ 10:28AM
Source : Dow Jones News
Stock : Astrazeneca Plc (AZN)
Quote : 7258.0  29.0 (0.40%) @ 4:35PM
Astrazeneca share price Chart

LONDON MARKETS: Brexit Stockpiling Shows Up In Manufacturing Data And Bakery Results

Greggs (LSE:GRG)
Historical Stock Chart

3 Months : From Sep 2019 to Dec 2019

Click Here for more Greggs Charts.

By Steve Goldstein, MarketWatch

The extent of stockpiling ahead of a possible hard Brexit was on display in Tuesday in areas ranging from manufacturing data to a bakery's results.

U.K. manufacturing PMI rose to a four-month high in September -- but driven by stockpiling, IHS Markit said.

Levels of output, new orders, new export business and employment fell while those for stocks or purchases and input buying volumes rose, IHS Markit said as the headline index rose to 48.3 in September from 47.4 in August.

Baker Greggs (GRG.LN) meanwhile said it was preparing for the potential impact of the U.K.'s departure from the European Union "by building stocks of key ingredients and equipment that could be affected by disruption to the flow of goods into the U.K." The company said it's seeing pressure on both labor and food input costs.

Greggs said it was reiterating its full-year forecast as same-store sales in the 13 weeks to Sept. 28 rose 7.4%, which is slower than the 9.4% growth in the nine months to Sept. 28. "This was inevitable at some point, and whilst the company's guidance remains unchanged, this may encourage (remaining) momentum investors to look elsewhere," said analysts at Barclays of the slowing sales growth.

Greggs shares tumbled 6.4%.

   The FTSE 100   more broadly declined 0.12% to 7399.39. 

Gainers included plumbing and heating products distributor Ferguson (FERG.LN) , which rose 4.6% as it reported a rise in pretax profit for the fiscal year on 6.1% revenue growth, and said it was outperforming the U.S. market.

AstraZeneca PLC (AZN.LN) slipped 1.7% as it said the U.S. Food and Drug Administration hadn't approved its new drug application for PT010, an inhaled treatment for chronic obstructive pulmonary disease.


(END) Dow Jones Newswires

October 01, 2019 06:13 ET (10:13 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20191207 07:19:54